HLA-DR antibody and antigen presentation reagents for the most polymorphic proteins

Designing a presentation experiment

1. Establish what allele groups the clone covers. Datasheets vary in how clearly they state this, and it is the single most important property. A pan reagent against a conserved framework region is safer than an allele specific one when total surface expression is the question.
2. Use a partner chain as a cross check. The invariant light chain of class I is not polymorphic, so a reagent against it gives an allele independent measure of surface class I. Disagreement between it and a heavy chain reagent is informative.
3. Interpret loss with two independent reagents. Apparent downregulation with one clone can be an allele the clone does not see. Two reagents recognising different regions, agreeing, is the minimum for a loss claim.
4. Include an interferon treated positive control. Presentation molecules are strongly induced by interferon, which gives a reliable high expression control and shows the stain has dynamic range on your cells.
5. Separate surface from total. Total protein can be unchanged while surface presentation collapses, because the block is in loading or trafficking. Surface staining of live cells answers the question that a permeabilised stain does not.

Polymorphism is the technical problem

Everywhere else in immunostaining, a reagent either binds the target or does not. Here it binds some versions of the target and not others, and the versions are distributed across donors in a way that correlates with ancestry.

That makes reagent choice an equity issue as well as a technical one in human studies: a clone with uneven allele coverage produces systematically different results in different populations.

Surface is the biology

What matters for presentation is molecules on the surface with peptide loaded. Total protein measured in a lysate can be normal while the surface is empty because loading or trafficking is blocked.

Stain live cells without permeabilisation when surface expression is the claim, and say so in the methods. It is a different measurement from the permeabilised one and readers cannot tell which was done unless it is stated.

cd3 antibodies and the chain they usually mean

The receptor complex has several chains and most cd3 antibodies are raised against the epsilon chain, which is what makes them pan T cell reagents. For flow cytometry the clone and the conjugate matter more than the catalogue name, since brightness decides whether a dim population is resolved. For tissue the epitope has to survive fixation, and a clone validated only for flow is not evidence that it stains a section.

A cd43 antibody and the glycoforms a clone can miss

CD43 is heavily glycosylated and its apparent mass moves with the cell type, so a cd43 antibody can appear to fail when it is reading a glycoform it was not raised against. Clones raised against the protein backbone and clones raised against a carbohydrate dependent epitope give different answers on the same sample. The datasheet should say which, and a positive control cell line of the same lineage is what settles it.

A cd90 antibody on Thy-1 across species

Thy-1 is a small GPI anchored protein whose expression differs sharply between human and mouse, where it marks different populations, so a cd90 antibody validated in one species proves nothing about the other. It is used as a mesenchymal and stromal marker in human work and as a T cell marker in mouse. Check the species, the isoform and whether the clone was raised against the native surface protein rather than a peptide.

A cd86 antibody and the activation state it reports

This costimulatory molecule is low on resting antigen presenting cells and rises on activation, so a cd86 antibody is bought to measure a change rather than a presence, and the unstimulated control is the measurement's other half. In flow cytometry a bright conjugate and a clear isotype control are what separate a genuine shift from autofluorescence. Blocking experiments need a functional grade clone, which is a separate validation.

A cd66b antibody as a neutrophil activation marker

CD66b is restricted to granulocytes and rises on degranulation, which makes a cd66b antibody a direct readout of activation in whole blood work. Because the epitope sits in a family with close relatives, the clone has to be stated as specific to that member. Sample handling dominates the result here: time on the bench, temperature and any centrifugation step will activate cells before the antibody ever touches them.

A baff antibody and the soluble form beside the membrane one

BAFF exists as a membrane protein and as a cleaved soluble trimer, and most clinical interest is in the soluble pool measured by immunoassay. A baff antibody for a blot or a section is therefore a different reagent from a matched capture and detection pair for the soluble form. Where a serum figure is the readout, the assay's calibration and its stated drug interference matter more than the clone.

An nkg2d antibody and the ligands its signal depends on

NKG2D is an activating receptor whose surface level falls when its ligands are present, so an nkg2d antibody can read low in exactly the biology of interest. That makes the paired ligand stain part of the interpretation rather than an extra. For functional work the clone has to be stated as blocking or non blocking, because a non blocking clone reports the receptor while a blocking one changes the experiment.

Common questions

Why do two donors stain so differently with an HLA-A antibody?

Frequently genotype rather than expression. Clones recognise epitopes present in some allele groups and absent in others, which is why a framework or partner chain reagent is safer for comparing donors.

How should loss of presentation be demonstrated?

With two independent reagents, a surface rather than total measurement, and an interferon treated positive control on the same cells. One clone showing reduced staining is not sufficient.

What is a good positive control?

Interferon treatment, which strongly induces presentation molecules on most cell types. It calibrates the upper end of the stain and confirms the reagent detects induction.

Browse by service class

• Compare Gene synthesis on advertised prices